Muutke küpsiste eelistusi

How to Design, Analyse and Report Cluster Randomised Trials in Medicine and Health Related Research [Other digital carrier]

(Medical Statistics Group, School of Health and Related Research, University of Sheffield, UK), (Medical Statistics Group, School of Health and Related Research, University of Sheffield, UK)
  • Formaat: Other digital carrier, 272 pages, kõrgus x laius x paksus: 229x152x15 mm, kaal: 666 g
  • Ilmumisaeg: 07-Apr-2014
  • Kirjastus: John Wiley & Sons Inc
  • ISBN-10: 1118763459
  • ISBN-13: 9781118763452
Teised raamatud teemal:
How to Design, Analyse and Report Cluster Randomised Trials in Medicine and  Health Related Research
  • Formaat: Other digital carrier, 272 pages, kõrgus x laius x paksus: 229x152x15 mm, kaal: 666 g
  • Ilmumisaeg: 07-Apr-2014
  • Kirjastus: John Wiley & Sons Inc
  • ISBN-10: 1118763459
  • ISBN-13: 9781118763452
Teised raamatud teemal:
A complete guide to understanding cluster randomised trials

Written by two researchers with extensive experience in the field, this book presents a complete guide to the design, analysis and reporting of cluster randomised trials. It spans a wide range of applications: trials in developing countries, trials in primary care, trials in the health services. A key feature is the use of R code and code from other popular packages to plan and analyse cluster trials, using data from actual trials.  The book contains clear technical descriptions of the models used, and considers in detail the ethics involved in such trials and the problems in planning them. For readers and students who do not intend to run a trial but wish to be a critical reader of the literature, there are sections on the CONSORT statement, and exercises in reading published trials.

  • Written in a clear, accessible style
  • Features real examples taken from the authors&; extensive practitioner experience of designing and analysing clinical trials
  • Demonstrates the use of R, Stata and SPSS for statistical analysis
  • Includes computer code so the reader can replicate all the analyses
  • Discusses neglected areas such as ethics and practical issues in running cluster randomised trials

How to Design, Analyse and Report Cluster Randomised Trials in Medicine and Health Related Research provides an excellent reference tool and can be read with profit by statisticians, health services researchers, systematic reviewers and critical readers of cluster randomised trials.

Preface xiii Acronyms and abbreviations xv 1 Introduction 1 1.1
Randomised controlled trials 1 1.1.1 A-Allocation at random 1 1.1.2
B-Blindness 2 1.1.3 C-Control 2 1.2 Complex interventions 3 1.3 History of
cluster randomised trials 4 1.4 Cohort and field trials 4 1.5 The
field/community trial 5 1.5.1 The REACT trial 5 1.5.2 The Informed Choice
leaflets trial 6 1.5.3 The Mwanza trial 7 1.5.4 The paramedics practitioner
trial 7 1.6 The cohort trial 8 1.6.1 The PoNDER trial 8 1.6.2 The DESMOND
trial 9 1.6.3 The Diabetes Care from Diagnosis trial 10 1.6.4 The REPOSE
trial 11 1.6.5 Other examples of cohort cluster trials 11 1.7 Field versus
cohort designs 11 1.8 Reasons for cluster trials 12 1.9 Between- and
within-cluster variation 14 1.10 Random-effects models for continuous
outcomes 15 1.10.1 The model 15 1.10.2 The intracluster correlation
coefficient 16 1.10.3 Estimating the intracluster correlation (ICC)
coefficient 16 1.10.4 Link between the Pearson correlation coefficient and
the intraclass correlation coefficient 17 1.11 Random-effects models for
binary outcomes 18 1.11.1 The model 18 1.11.2 The ICC for binary data 19
1.11.3 The coefficient of variation 19 1.11.4 Relationship between cvc and
for binary data 20 1.12 The design effect 20 1.13 Commonly asked questions
21 1.14 Websources 21 Exercise 22 Appendix 1.A 22 2 Design issues 27 2.1
Introduction 27 2.2 Issues for a simple intervention 28 2.2.1 Phases of a
trial 28 2.2.2 Pragmatic and explanatory trials 29 2.2.3
Intention-to-treat and per-protocol analyses 29 2.2.4 Non-inferiority and
equivalence trials 30 2.3 Complex interventions 30 2.3.1 Design of complex
interventions 30 2.3.2 Phase I modelling/qualitative designs 32 2.3.3 Pilot
or feasibility studies 33 2.3.4 Example of pilot/feasibility studies in
cluster trials 33 2.4 Recruitment bias 34 2.5 Matched-pair trials 34 2.5.1
Design of matched-pair studies 34 2.5.2 Limitations of matched-pairs designs
36 2.5.3 Example of matched-pair design: The Family Heart Study 36 2.6
Other types of designs 37 2.6.1 Cluster factorial designs 37 2.6.2 Example
cluster factorial trial 38 2.6.3 Cluster crossover trials 38 2.6.4 Example
of a cluster crossover trial 39 2.6.5 Stepped wedge 39 2.6.6
Pseudorandomised trials 40 2.7 Other design issues 41 2.8 Strategies for
improving precision 41 2.9 Randomisation 42 2.9.1 Reasons for randomisation
42 2.9.2 Simple randomisation 43 2.9.3 Stratified randomisation 43 2.9.4
Restricted randomisation 43 2.9.5 Minimisation 44 Exercise 45 Appendix 2.A
48 3 Sample size: How many subjects/clusters do I need for my cluster
randomised controlled trial? 50 3.1 Introduction 51 3.1.1 Justification of
the requirement for a sample size 51 3.1.2 Significance tests, P-values and
power 51 3.1.3 Sample size and cluster trials 53 3.2 Sample size for
continuous data comparing two means 53 3.2.1 Basic formulae 53 3.2.2
The design effect (DE) in cluster RCTs 54 3.2.3 Example from general
practice 55 3.3 Sample size for binary data comparing two proportions 56
3.3.1 Sample size formula 56 3.3.2 Example calculations 57 3.3.3 Example:
The Informed Choice leaflets study 58 3.4 Sample size for ordered
categorical (ordinal) data 59 3.4.1 Sample size formula 59 3.4.2 Example
calculations 60 3.5 Sample size for rates 62 3.5.1 Formulae 62 3.5.2
Example comparing rates 63 3.6 Sample size for survival 63 3.6.1 Formulae
63 3.6.2 Example of sample size for survival 64 3.7
Equivalence/non-inferiority studies 64 3.7.1 Equivalence/non-inferiority
versus superiority 64 3.7.2 Continuous data comparing the equivalence of
two means 65 3.7.3 Example calculations for continuous data 65 3.7.4 Binary
data comparing the equivalence of two proportions 66 3.8 Unknown
standard deviation and effect size 66 3.9 Practical problems 67 3.9.1 Tips
on getting the SD 67 3.9.2 Non-response 67 3.9.3 Unequal groups 67 3.10
Number of clusters fixed 68 3.10.1 Number of clusters and number of subjects
per cluster 68 3.10.2 Example with number of clusters fixed 69 3.10.3
Increasing the number of clusters or number of patients per cluster? 69 3.11
Values of the ICC 69 3.12 Allowing for imprecision in the ICC 70 3.13
Allowing for varying cluster sizes 70 3.13.1 Formulae 70 3.13.2 Example of
effect of variable cluster size 71 3.14 Sample size re-estimation 71 3.14.1
Adjusting for covariates 72 3.15 Matched-pair studies 72 3.15.1 Sample
sizes for matched designs 72 3.15.2 Example of a sample size calculation for
a matched study 72 3.16 Multiple outcomes/endpoints 73 3.17 Three or more
groups 74 3.18 Crossover trials 74 3.18.1 Formulae 75 3.18.2 Example of a
sample size formula in a crossover trial 75 3.19 Post hoc sample size
calculations 75 3.20 Conclusion: Usefulness of sample size calculations 76
3.21 Commonly asked questions 76 Exercise 77 Appendix 3.A 78 4 Simple
analysis of cRCT outcomes using aggregate cluster-level summaries 83 4.1
Introduction 83 4.1.1 Methods of analysing cluster randomised trials 83
4.1.2 Choosing the statistical method 84 4.2 Aggregate cluster-level
analysis carried out at the cluster level, using aggregate summary data
84 4.3 Statistical methods for continuous outcomes 86 4.3.1 Two
independent-samples t-test 86 4.3.2 Example 88 4.4 Mann Whitney U test 91
4.5 Statistical methods for binary outcomes 94 4.6 Analysis of a matched
design 95 4.7 Discussion 98 4.8 Commonly asked question 98 Exercise 99
Appendix 4.A 99 5 Regression methods of analysis for continuous outcomes
using individual person-level data 102 5.1 Introduction 102 5.2 Incorrect
models 104 5.2.1 The simple (independence) model 104 5.2.2 Fixed effects
104 5.3 Linear regression with robust standard errors 105 5.3.1 Robust
standard errors 105 5.3.2 Example of use of robust standard errors 107
5.3.3 Cluster-specific versus population-averaged models 107 5.4
Random-effects general linear models in a cohort study 108 5.4.1 General
models 108 5.4.2 Fitting a random-effects model 109 5.4.3 Example of a
random-effects model from the PoNDER study 110 5.4.4 Checking the
assumptions 110 5.5 Marginal general linear model with coefficients
estimated by generalised estimating equations (GEE) 112 5.5.1 Generalised
estimating equations 112 5.5.2 Example of a marginal model from the PoNDER
study 113 5.6 Summary of methods 114 5.7 Adjusting for individual-level
covariates in cohort studies 115 5.8 Adjusting for cluster-level covariates
in cohort studies 118 5.9 Models for cross-sectional designs 119 5.10
Discussion of model fitting 120 Exercise 122 Appendix 5.A 123 6 Regression
methods of analysis for binary, count and time-to-event outcomes for a
cluster randomised controlled trial 126 6.1 Introduction 126 6.2 Difference
between a cluster-specific model and a population-averaged or marginal model
for binary data 127 6.3 Analysis of binary data using logistic regression
129 6.4 Review of past simulations to determine efficiency of different
methods for binary data 130 6.5 Analysis using summary measures 131 6.6
Analysis using logistic regression (ignoring clustering) 132 6.7
Random-effects logistic regression 134 6.8 Marginal models using generalised
estimating equations 135 6.9 Analysis of count data 135 6.10 Survival
analysis with cluster trials 137 6.11 Missing data 139 6.12 Discussion 139
Exercise 139 Appendix 6.A 140 7 The protocol 143 7.1 Introduction 143 7.2
Abstract 144 7.3 Protocol background 147 7.4 Research objectives 147 7.5
Outcome measures 147 7.6 Design 147 7.7 Intervention details 148 7.8
Eligibility 148 7.9 Randomisation 149 7.10 Assessment and data collection
149 7.11 Statistical considerations 150 7.11.1 Sample size 150 7.11.2
Statistical analysis 151 7.11.3 Interim analyses 152 7.12 Ethics 153
7.12.1 Declaration of Helsinki 153 7.12.2 Informed consent 154 7.13
Organisation 155 7.13.1 The team 155 7.13.2 Trial forms 155 7.13.3 Data
management 155 7.13.4 Protocol amendments 156 7.14 Further reading 156
Exercise 156 8 Reporting of cRCTs 159 8.1 Introduction: Extended CONSORT
guidelines for reporting and presenting the results from cRCTs 159 8.2
Patient flow diagram 160 8.3 Comparison of entry characteristics 160 8.4
Incomplete data 167 8.5 Reporting the main outcome 171 8.6 Subgroup
analysis and analysis of secondary outcomes/endpoints 174 8.7 Estimates of
between-cluster variability 175 8.7.1 Example of reporting the ICC: The
PoNDER cRCT 175 8.8 Further reading 175 Exercise 176 9 Practical issues
178 9.1 Preventing bias in cluster randomised controlled trials 178 9.1.1
Problems with identifying and recruiting patients to cluster trials 178
9.1.2 Preventing biased recruitment 179 9.2 Developing complex interventions
181 9.3 Choice of method of analysis 182 9.4 Missing data 185 9.5 Example
sensitivity analysis: Imputation of missing 6-month EPDS data for at-risk
women from the PoNDER cRCT 188 9.6 Multiplicity of outcomes 192 9.6.1
Limiting the number of confirmatory tests 192 9.6.2 Summary measures and
statistics 193 9.6.3 Global tests and multiple comparison procedures 193
9.6.4 Which multiple comparison procedure to use? 194 10 Computing software
195 10.1 R 195 10.1.1 History 195 10.1.2 Installing R 196 10.1.3 Simple
use of R 197 10.1.4 An example of an R program 198 10.2 Stata (version 12)
199 10.2.1 Introduction to Stata 199 10.2.2 Aggregate cluster-level
analysis carried out at the cluster level, using aggregate summary data
201 10.2.3 Random-effects models continuous outcomes 202 10.2.4
Random-effects models binary outcomes 205 10.2.5 Random-effects models
count outcomes 206 10.2.6 Marginal models continuous outcomes 208
10.2.7 Marginal models binary outcomes 209 10.2.8 Marginal models
count outcomes 210 10.3 SPSS (version 19) 212 10.3.1 Introduction to SPSS
212 10.3.2 Comparing cluster means using aggregate cluster-level analysis
carried out at the cluster level, using aggregate summary data 213 10.3.3
Marginal models 215 10.3.4 Random-effects models 227 10.4 Conclusion and
further reading 232 References 234 Index 243